BLOOMIOS, INC. Financial Statements and Exhibits (form 8-K/A)
January 05, 2023 at 04:59 pm EST
Share
Item 9.01 Financial Statements and Exhibits.
(a) Financial Statements of Businesses Acquired
The audited financial statements of Infusionz as of and for the years
ended June 30, 2021 and 2022, and the related Independent Auditor's Report
are filed hereto as Exhibit 99.1 and incorporated herein by reference.
(b) Financial Statements of Businesses Acquired
The unaudited financial statements of Infusionz as of and for the three
months ended September 30, 2022, are filed hereto as Exhibit 99.2 and
incorporated herein by reference.
(c) Pro Forma Financial Information
The unaudited Pro Forma Condensed Combined Balance Sheet of Bloomios, Inc.
and Infusionz as of September 30, 2022, Unaudited Pro Forma Condensed
Combined Statement of Income of Bloomios, Inc. and Infusionz for the year
ended June 30, 2022, Unaudited Pro Forma Condensed Combined Statement of
Income of Bloomios, Inc. and Infusionz for the three months ended
September 30, 2022 are filed hereto as Exhibit 99.3 and incorporated
herein by reference.
(d) Exhibits
Exhibit No. Exhibit Description
23.1 Consent of B F Borgers CPA PC
99.1 Audited financial statements of Infusionz as of and for the years
ended June 30, 2021 and 2022, and the related Independent Auditor's
Report
99.2 The unaudited financial statements of Infusionz as of and for the
three months ended September 30, 2022.
99.3 Unaudited Pro Forma Condensed Balance Sheet of Bloomios, Inc. and
Infusionz as of September 30, 2022, Unaudited Pro Forma Condensed
Combined Statement of Income of Bloomios, Inc. and Infusionz for the
year ended June 30, 2022, and the Unaudited Pro Forma Condensed Combined
Statement of Income of Bloomios, Inc. and Infusionz for the three months
ended September 30, 2022
104 Cover Page Interactive Data File (embedded within the Inline XBRL
Document).
2
Bloomios, Inc. manufactures, markets, and distributes hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States, through its wholly owned subsidiary, Bloomios Private Label (BPL). BPL is engaged in the manufacturing, processing, sourcing and distribution of hemp-derived, nootropic and nutraceutical products to wholesalers and retailers. The Company manufactures hemp infused products ranging from human edibles, pet edibles, liquid consumables such as tinctures and shots, topicals, and smokable hemp. It provides support at each step from custom formulation, order fulfillment, and brand development. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages and pet treats. It offers its private-label and white-label customers a collections of customizable hemp products that includes over 80 products across seven categories in addition to custom formulation and manufacturing services.
BLOOMIOS, INC. 
